Band Aid Drug Delivery Company Partners With Manufacturer
a University of Warwick spin-out company developing a novel transdermal drug delivery patch technology, has appointed Laboratoires Plasto Santé to manufacture its first drug delivery patches.
The first batch of patches, based on Medherant’s proprietary TEPI Patch® technology, will be used for clinical studies of the company’s revolutionary ibuprofen patches. The new studies, designed to test safety and efficacy, are planned to start in the autumn of 2017.
Nigel Davis, CEO of Medherant, said, “We’re delighted to have Laboratoires Plasto Santé as our contract manufacturer at this exciting time in our company’s growth. Combining our TEPI Patch® technology with Laboratoires Plasto Santé’s product manufacturing expertise will enable us to start clinical trials and facilitate rapid growth of our library of patch-delivered drugs.”
Bruno Loiseau, Managing Director of Laboratoires Plasto Santé, said “We’re looking forward to working with Medherant as it progresses its patches towards the market. We are expanding our patch production capacity and will support Medherant with our expertise in transdermal delivery systems as they bring TEPI Patch® ibuprofen to market and begin clinical studies with other products.”
Penn Medicine Biochemist Receives Major Award for Research on Epigenetic Protein Modifications via Mass SpecNews
Benjamin A.Garcia, PhD, an expert in quantitative proteomics and Presidential Professor of Biochemistry and Biophysics in the Perelman School of Medicine at the University of Pennsylvania, has been awarded the Biemann Medal by the American Society for Mass Spectrometry (ASMS). The early-career award recognizes significant achievement in basic or applied mass spectrometry.
New Speakers from Roche and Imperial College London Announced for SMi’s ADMET EventNews
SMi Group Reports: With less than 4 weeks left until the 13th annual ADMET Conference commences in London, SMi announces two new speakers joining the event.READ MORE